Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

Goel, Rishi R., Apostolidis, Sokratis A., Painter, Mark M., Mathew, Divij, Pattekar, Ajinkya, Kuthuru, Oliva, Gouma, Sigrid, Hicks, Philip +23 more·2021·Science Immunology

Cited by (641)

Items 601–641 of 641

  1. Circulating Antibodies Against Common Cold Coronaviruses Do Not Interfere with Immune Responses to Primary or Booster SARS-CoV-2 mRNA Vaccines
    Bindu Adhikari, Eugene M. Oltz, Richard J. Gumina, Maryssa K. Kick, Linda J. Saif, Anastasia Nickolaevna Vlasova · 2025 · Vaccines
  2. BAFF-R and CD21 dysregulation inhibits memory B cell persistence in patients with common variable immunodeficiency
    Mike Bogetofte Barnkob, Emilie Stavnsbjerg Larsen, Anna Christine Nilsson, Zelvera Usheva, Caroline Louise Stougaard, Nina Bang, Emil Birch Christensen, Kim Martin Rasmussen, Line Lundegaard Bang, Ditte Rask Tornby et al. · 2025 · medRxiv
  3. Efficacy of Heterologous Immunization and Hybrid Immunity as Vaccination Strategies During the COVID-19 Pandemic: A Narrative Review of the Literature
    Franklin Enrique Torres Jimenez, Maria Fernanda Torres-Ferias, Adalgisa Esther Alcocer-Olaciregui, Hector Mario Rodriguez-Ortiz, Evelyn Mendoza‐Torres, Karen Patricia Torres-Rodriguez · 2025 · Preprints.org
  4. The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination
    Wanitchaya Kittikraisak, Chaniya Leepiyasakulchai, Chutiphon Saelee, Chuleekorn Tanathitikorn, Patama Suttha, Somsak Punjasamanvong, Phunlerd Piyaraj, Thanapat Wongrapee, Pornsak Yoocharoen, Suthat Chottanapund et al. · 2025 · Scientific Reports
  5. COVID-19 vaccination-infection status and immunological profile from India: A case study for prioritizing at risk population for targeted immunization
    Deepika Gujjarlapudi, Ankit Mittal, Vidyavathi Devi Gajapathi Raju, Sadhana Yelamanchili Veturi, Rupjyoti Talukdar, Rupa Banerjee, Nitin Jagtap, Sannapaneni Krishnaiah, Namburu Veeraiah, Nageshwar Reddy Duvvur · 2025 · Journal of Family Medicine and Primary Care
  6. No, los efectos secundarios de las vacunas no son una señal de que tu sistema inmunitario te protegerá mejor
    Robert W. Finberg · 2021
  7. Comparing neutralizing antibody activity over time between naïve and convalesced COVID-19 vaccinated individuals
    Lisette G. de Pillis, Rebecca Caffrey, Ge Chen, Mark Dela, Leif Eldevik, Hong Liu, Joseph P. McConnell, Shahrokh Shabahang, Stephen A. Varvel · 2025 · Scientific Reports
  8. Longitudinal T- and B-cell recall response after vaccination with Pfizer-BioNTech mRNA vaccine BNT162b2
    Youmna El-Orfali, Rana Mansour, Habib Alkalamouni, Ziad C. Jabbour, Antoine G. Abou Fayad, Esber S. Saba, Ghada Khawaja, Michel J. Massaad · 2025 · Journal of Allergy and Clinical Immunology
  9. Dynamics of B-cell response in MERS-CoV patients and survivors with hybrid immunity
    Hebah A. Al-Khatib, Fatma H. Ali, Hadeel T. Zedan, Maria K. Smatti, Peter Valentine Coyle, Sara Taleb, Ali Ait Hssain, Asmaa A. Al Thani, Hadi Mohamad Yassine · 2025 · mBio
  10. Additional file 1 of Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
    Enrico Lavezzo, Monia Pacenti, Laura Manuto, Caterina Boldrin, Margherita Cattai, Marco Grazioli, Federico Bianca, Margherita Sartori, Federico Caldart, Gioele Castelli et al. · 2022 · Figshare
  11. Additional file 1 of Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections
    Yoon, Sun-Woo, Kristin Widyasari, Jang, Jieun, Lee, Seungjun, Kang, Taejoon, Kim, Sunjoo · 2024 · Figshare
  12. Additional file 1 of The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection
    Eleonora Vecchio, Salvatore Rotundo, Claudia Veneziano, Antonio Abatino, Ilenia Aversa, Raffaella Gallo, Caterina Giordano, Francesca Serapide, Paolo Fusco, Giuseppe Viglietto et al. · 2024 · Figshare
  13. No, vaccine side effects don’t tell you how well your immune system will protect you from COVID-19
    Robert W. Finberg · 2021
  14. Whole blood transcriptional responses associated with bacterial burden in pulmonary tuberculosis
    Le Thanh Hoang Nhat, Triet Minh Thai, Hoang Thanh Hai, Le Hong Van, Le Nguyen Hong Thai, Trinh Thi Bich Tram, Do Dang Anh Thu, Thi Minh Ha Dang, Nghia Ho Dang Trung, Guy Edward Thwaites et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Antibody Responses to COVID-19 Vaccination or Infection in Actively Treated Cancer Patients: A Prospective Cohort Study
    Laura Q. Wang, Lina W. Smith · 2025 · Asian journal of Current Research in Clinical Cancer
  16. Evaluación de la inmunidad híbrida y comorbilidades en el sector educativo de México: perspectivas de la vacunación con Cansino/Moderna contra el SARS-CoV-2
    Jocelyn C. Pérez-Lara, Joel Jahaziel Díaz-Vallejo, Jesús Oswaldo Hernández Casiano, Carlos Arturo Gallardo-Hernández · 2025 · Revista de Salud Pública
  17. The comparison of Immune response to Third booster dose with of Vaxzevria or Comirnaty COVID-19 vaccine in healthcare workers after receiving two doses of CoronaVac
    Auchara Tangsathapornpong, Sudatip Kositamongkol, Pornpimon Angkasekwinai, Peera Jaru-Ampornpan, Pornumpa Bunjoungmanee, Prapasri Kulalert, Patcharaporn Punyashthira, Sira Nanthapisal · 2026 · Vaccine X
  18. Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance study
    Lourrany Borges Costa, Francisca Kalline de Almeida Barreto, Patrícia Pereira Lima Barbosa, Magda Moura de Almeida, Antônia Luciana Souza Bekman, Silvana Soares de Souza, Ana Carolina Barjud Marques Máximo, Debora Bezerra Silva, Carlos Henrique Alencar, Luciano Pamplona de Góes Cavalcanti · 2026 · BMC Infectious Diseases
  19. Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy
    Sigrun Einarsdottir, Teng Fei, Katina H. Singh, Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch et al. · 2026 · Blood Advances
  20. Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
    Aurélien Sokal · 2022 · theses.fr (ABES)
  21. Prise en charge d’une infection virale chronique (BK polyomavirus) et d’une infection virale aigue (SARS-CoV-2) dans une population de transplantés rénaux
    Iliès Benotmane · 2022 · theses.fr (ABES)
  22. A Longitudinal Exploratory Study of SARS-CoV-2 Antibody Dynamics in Young Adults in Bogotá: Lessons from Natural Infection and Post-Vaccination Memory
    María F. Naranjo-Ortíz, Luz A. Parada, José G. Fuentes-Montoya, Jean Carlos Villamil Poveda, Francy Elaine Torres-Suarez, H Diaz, Laura Daniela Ardila Ortiz, Juliana Velosa Porras, Lorenza Jaramillo, Jorge Andrés Castillo et al. · 2026 · Biomedicines
  23. Mechanisms underlying immunodynamics of layered defenses elicited by mRNA vaccination in children
    Yiyu Liao, Hoong Kai Chua, Boon Kiak Lau, Yuqian Wang, Franciszek Polak, Allyson N. X. Choi, Carina Jing Xuan Tay, Huien Li, L. Shek, Elizabeth Huiwen Tham et al. · 2026 · BMC Medicine
  24. Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review
    Sumel Ashique, Mohini Mondal, Md Sadique Hussain, Anas Islam, Mohd Tariq, Dinesh Kumar Chellappan, Sabina Yasmin, Tabarak Malik, Juberahamad Rajjak Attar, Md Yousuf Ansari · 2026 · Inflammopharmacology
  25. Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of insufficient immunological memory or sufficient protection against re-infection - a Target to B! substudy
    Luuk Wieske, Koos P J van Dam · 2025 · Pure Amsterdam UMC
  26. COVID-19 vaccination and antibody response in healthcare workers: a longitudinal serological study following the 2023–2024 COVID-19 vaccination campaign
    Joao Eduardo Guarnetti dos Santos, Camila Valadas Henriques, Palmira Amaral, Raquel Guiomar, Ausenda Machado, Vânia Gaio · 2026 · BMC Infectious Diseases
  27. Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacy
    Jinpeng Su, Youssef Hamway, Daniele Mistretta, Bo‐Hung Liao, Zhe Ma, Julia Schluckebier, Zhe Xie, Olga Polezhaeva, Walaa Jradi, Sarah Braun et al. · 2026 · Frontiers in Immunology
  28. Linking Host Covariates to COVID-19 Vaccine-Induced Antibody Dynamics in a Large Healthcare Worker Cohort
    Clemens Peiter, Emma Sala, Giuseppe De Palma, Carlotta Zunarelli, Michelle B. Hanson, Mahsa Abedini, Evelina Tacconelli, Paolo Boffetta, Jan Hasenauer · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Clinical and Humoral Immune Features of Post-COVID Syndrome One Year After SARS-CoV-2 Infection in Elderly Patients with Type 2 Diabetes
    Svetlana Bolshakova, Saule Altynbekova, Zhangentkhan Abylaiuly, Gulim Aldangarova · 2026 · Viruses
  30. Dynamics of Circulating Follicular Helper and Regulatory T‐Cell Memory Induced by mRNA, Inactivated, and Live‐Attenuated Vaccines
    A. China, A. Rahman, L. Hani, M. Kumamoto, Mathieu Surénaud, Colas Tchérakian, Véronique Godot, Takuto Nogimori, Jean‐Daniel Lelièvre, Yves Lévy et al. · 2026 · Journal of Immunology Research
  31. Evaluating Memory B Cell Cross-Reactivity Between Ancestral and Future SARS-CoV-2 Variants—Evidence for Original Antigenic Sin
    Lingling Yao, Zoltán Megyesi, Paul V Lehmann, Greg A. Kirchenbaum · 2026 · Vaccines
  32. Twelve-month anti-SARS-CoV-2 antibody kinetics in COVID-19 patients from Bejaia, Algeria
    Sabrine Boufarou, N. Achour, Ines Allam, Réda Djidjik · 2026 · Microbes & Immunity
  33. Durability of COVID-19 vaccine-induced immunity in Saudi Arabia: evidence, gaps, and implications for Hajj and mass-gathering preparedness
    Leena E Azhar, Ahdab Alsaieedi, Mariam M. AlEissa, Hussain A. Baroom, Amro H. Alghoraibi, Khalid S. Alzahrani, Esam I. Azhar · 2026 · Frontiers in Public Health
  34. Germline based SARS-CoV-2 specific B cell repertoire motif identified with novel sequence based bioinformatic pipeline
    Daniel Fridman, Lena Israitel, Areen Shtewe, Uri Hershberg · 2026 · Frontiers in Immunology
  35. Association between Coronavirus Disease 2019 Vaccination and Fatigue Outcomes: Postvaccine Syndrome Risk in a Cross-sectional Study
    Amal Daher Alshammari, Mubashir Zafar, Fay Khalid Alshabrami, Shouq Basheer Alshammari · 2026 · Asian Journal of Pharmaceutical Research and Health Care
  36. Dynamics of neutralizing antibody responses after trivalent XBB.1.5 booster vaccination: a 480-day longitudinal study
    Meng-Fei Wang, Guo-Ping Cao, Guojian Yang, Xuedong Song, Bingdong Zhan, Mai‐Juan Ma · 2026 · Signal Transduction and Targeted Therapy
  37. Longitudinal analysis of hybrid immunity in a Vietnamese COVID-19 cohort demonstrates vaccination-associated broadening of cross-variant neutralization across diverse HLA backgrounds
    Thi Thanh Ngan Nguyen, Kim Mai Huỳnh, Hien Anh Thi Nguyen, Hung Thai Do, Kouichi Morita, Futoshi Hasebe, Thi Quynh Mai Le, Takashi Shiina, Lay‐Myint Yoshida, Meng Ling Moi · 2026 · Frontiers in Immunology
  38. Longitudinal antibody correlates of SARS-CoV-2 infection in a US household cohort during Omicron waves
    Yangyupei Yang, Amy P. Callear, Matthew Smith, Casey L. Juntila-Raymond, Elie-Tino Godonou, Emileigh Johnson, Adam S. Lauring, William J. Fitzsimmons, Jefferson M. Jones, Claire M. Midgley et al. · 2026 · medRxiv
  39. Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides Enhances mRNA Efficacy via Reduced Endosomal Retention
    Yuxin He, Lin Wang, Abigael P. Williams, Trisha I. Valerio, Yuanhong Sun, James Bowman, Samantha D. Ricketts, Savannah Hammond, Aidan Sison, Jezan Alexandre et al. · 2026 · ACS Nano
  40. Comparative analysis of SARS-CoV-2 immune memory in vaccinated and hybrid individuals two years post-exposure
    Czdari Lee, Imtisal Imran, Sara Thomas, Mahyar A Nouri-Shirazi · 2026 · Clinical Immunology Communications
  41. Analysis of cellular immune responses to Influenza vaccines
    Ted Ross · 2025 · ImmPort